Budd-Chiari syndrome associated with congenital afibrinogenaemia reversed after orthotopic liver transplant

BMJ Case Rep. 2024 Jul 3;17(7):e259078. doi: 10.1136/bcr-2023-259078.

Abstract

A woman in her mid-20s, a known case of congenital afibrinogenaemia, presented with abdominal pain and distension. She was diagnosed with decompensated liver cirrhosis due to Budd-Chiari syndrome. She underwent deceased donor liver transplantation. Preoperatively, her serum fibrinogen level was undetectable and prothrombin time and international normalised ratio (INR) were unrecordable. Intraoperatively, she was given thromboelastography-guided human fibrinogen concentrate. Postoperatively, her fibrinogen, prothrombin time and INR normalised rapidly. This report summarises the rare occurrence of a complication of hypercoagulability (Budd-Chiari syndrome) in the setting of congenital hypocoagulability (congenital afibrinogenaemia). In this report, we discuss the simultaneous management of these two clinical problems and the curative role of liver transplantation.

Keywords: Thrombosis; Transplantation.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Afibrinogenemia* / complications
  • Budd-Chiari Syndrome* / etiology
  • Female
  • Fibrinogen / therapeutic use
  • Humans
  • International Normalized Ratio
  • Liver Cirrhosis / complications
  • Liver Cirrhosis / surgery
  • Liver Transplantation*

Substances

  • Fibrinogen